Medified blalock-taussing shnt: a palliative procedure for congenital cyanotic heart disease
JSP-Journal of Surgery Pakistan International. 1999; 4 (4): 21-22
in English
| IMEMR
| ID: emr-51449
ABSTRACT
Systemic pulmonary arterial shunt procedure is used in the management of cyanotic congenital heart diseases. We are reporting our experience of 80 procedures with modified Blalock-Taussing shunt procedure in the management of cyanotic heart defects, from January 1994 to December 1994. The age of these patients was 3 months to 15 years. Forty-five [56.2 percent] presented with cyanotic spells and 35 [43.5 percent] were electively selected for surgery. The packed cell volume in majority of the patients ranged between 45 to 70 percent. Seventy-two [90.5 percent] cases received right-sided shunt. The hospital mortality was 5 percent. We conclude modified Blalock Taussing shunt is a useful palliative procedure in the management of cyanotic congenital cardiac defects
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Pulmonary Artery
/
Subclavian Artery
/
Surgical Procedures, Operative
/
Cyanosis
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
J. Surg. Pak. Int.
Year:
1999
Similar
MEDLINE
...
LILACS
LIS